Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / ARS Pharmaceuticals
Entity

ARS Pharmaceuticals

Tracked across 2 events · 68 articles · First seen Jun 26, 2026 · Last active Aug 20, 2026

Sentiment
-65
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 -70
Regulatory
ARS Pharmaceuticals Securities Investigation
Impact: ARS Pharmaceuticals is under investigation for potential violations of federal securities laws due to allegedly misleading statements regarding Neffy's commercial coverage, which led to a significant stock price drop.
Jun 26, 2026 · 6 articles
2 -60
Regulatory
ARS Pharmaceuticals Securities Fraud Class Action
Multiple law firms, including Bronstein, Gewirtz & Grossman, LLC, Rosen Law Firm, and Schall Brown & Schwartz LLP, have announced a securities class action lawsuit against ARS Pharmaceuticals Inc. (NASDAQ: SPRY) and certain officers. The…
Impact: ARS Pharmaceuticals is the defendant in the securities class action, facing allegations of misleading investors about neffy's insurance coverage timeline. The lawsuit could result in financial damages and reputational harm.
Aug 06, 2026 · 62 articles
Key Actions (11)
100 Bronstein, Gewirtz & Grossman, LLC filed class action ARS PharmaceuticalsARS Pharmaceuticals...
100 Rosen Law Firm filed class action ARS PharmaceuticalsARS Pharmaceuticals...
100 Schall Brown & Schwartz LLP filed class action ARS PharmaceuticalsARS Pharmaceuticals...
100 Faruqi & Faruqi filed securities class action ARS PharmaceuticalsARS Pharmaceuticals...
100 Levi & Korsinsky filed securities class action ARS PharmaceuticalsARS Pharmaceuticals...
100 Kaplan Fox & Kilsheimer filed class action ARS PharmaceuticalsARS Pharmaceuticals...
92 ARS Pharmaceuticals disclosed zero additionsARS Pharmaceuticals...
90 ARS Pharmaceuticals announced no expanded coverage CVS HealthARS Pharmaceuticals...
90 CVS Health reserved coverage decision ARS PharmaceuticalsARS Pharmaceuticals...
80 Pomerantz LLP filed class action ARS PharmaceuticalsARS Pharmaceuticals...
70 William Blair & Company lowered estimates ARS PharmaceuticalsARS Pharmaceuticals...
ERGEN INTELLIGENCE
Track ARS Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.